Sanofi terminates deal to exclusively license Maze Therapeutics Pompe disease drug Ruchika Sharma12 Dec 2023 2:30 PM ISTWashington: Sanofi has said it was terminating a deal to exclusively license a drug that Maze Therapeutics is developing to treat Pompe disease...
Sanofi Gets CDSCO Panel Nod To Market Avalglucosidase Alfa Powder for Pompe Disease Dr. Divya Colin28 Jan 2023 6:00 PM ISTNew Delhi: Granting a local Phase III and Phase IV clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
FDA approves new treatment for rare genetic disease- Pompe disease Dr. Kamal Kant Kohli6 Aug 2021 10:12 PM ISTThe U.S. Food and Drug Administration has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and...
First of its kind: Newborn diagnosed with two rare genetic diseases in Jaipur Medical Dialogues Bureau13 Sept 2020 9:00 AM ISTThe baby has been diagnosed with Pompe disease and Spinal Muscular Atrophy (SMA), a doctor at J K Lone Hospital said on Wednesday.
Delhi government forms a committee to tackle rare diseases Pooja Bhatia Bhatia5 Feb 2016 12:44 PM ISTA policy on rare genetic diseases like Progeria that causes premature ageing or Lysosomal storage disorders such as Pompe disease and Gaucher's...
